Peripheral Nervous System Diseases

5

Review clinical trials related to Peripheral Nervous System Diseases. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

A Phase 3 Study of NTLA-2001 in ATTRv-PN

This study will be conducted to evaluate the efficacy and safety of a single dose of nexiguran ziclumeran (NTLA-2001) compared to placebo in participants with ATTRv-PN.

Participants needed: 60
Trial details
Phase: Phase 3Age: 18-85Biological sex: AllType: InterventionalSponsor: Intellia TherapeuticsUpdated: Apr 16, 2026Locations: 14
Eligibility criteria

Diagnosis of ATTRv-PN [+1]

Other causes of amyloidosis (amyloidosis caused by non-TTR protein) [+9]

Status: Not yet recruiting

The Effect of Oral DLBS1033 in Patients With Diabetic Polyneuropathy

This study aims to evaluate whether oral DLBS1033 can improve clinical symptoms and biological markers of nerve damage in adults with diabetic polyneuropathy. The trial enrolls patients with type 2 diabetes who show clinical signs of peripheral nerve injury. Participants will receive either DLBS1033 as adjuvant therapy or standard therapy alone for 28 days. The study will compare changes in neuropathy severity (Toronto Clinical Neuropathy Score), inflammatory biomarkers (TNF-α), neuroregeneration biomarkers (Nerve Growth Factor), and sensory nerve conduction parameters of the sural nerve between the two groups. Blood tests, clinical assessments, and nerve conduction studies will be performed at baseline and follow-up visits. Participants will also report any symptoms or adverse events throughout the study.

Participants needed: 34
Trial details
Phase: Phase 2, Phase 3Age: 40-60Biological sex: AllType: InterventionalSponsor: Universitas Sebelas MaretUpdated: Mar 16, 2026Locations: 1
Eligibility criteria

Adults aged 40-60 years diagnosed with diabetic polyneuropathy by a neurologist... [+2]

Pregnant, breastfeeding, or planning pregnancy. [+8]

Status: Recruiting

The Effects of AFO Heel Height and Stiffness on Gait

The proposed study evaluates the effect of ankle foot orthosis (AFO) heel height and stiffness on the forces and motion of the lower limb during over-ground walking in individuals who use an AFO for daily walking. Previous studies suggest that heel height and stiffness effect limb loading, but these data and the analysis techniques applied are limited. In this study, heel cushions with different height and stiffness's (4 conditions) will be placed in participants shoes and they will walk at controlled and self-selected speeds. Participants will also walk with their AFO as configured prior to enrollment, and with no AFO if possible. The proposed study will provide evidence that can be used by clinicians and researchers to align braces that most effectively improve function during every-day walking.

Participants needed: 40
Trial details
Age: 18-70Biological sex: AllType: InterventionalSponsor: University of IowaUpdated: Dec 31, 2025Locations: 1
Eligibility criteria

Daily AFO use to address unilateral, below knee functional deficits that result... [+5]

Pain > 6/10 while walking during testing or an increase in pain during testing o... [+25]

Status: Not yet recruiting

Walking Ankle Robot for Foot Drop in Aging and Disabled Populations: A Demonstration Project

The purpose of this research study is to test the utility of an ankle robot, when used during treadmill walking, in people with ankle weakness and foot drop from a peripheral nervous system injury due to neuromuscular or orthopedic injury.

Participants needed: 100
Trial details
Age: 18-88Biological sex: AllType: InterventionalSponsor: Baltimore VA Medical CenterUpdated: Jun 14, 2018
Eligibility criteria

Men and women, aged 18 to 88 years [+2]

Cardiac history of (a) unstable angina; (b) recent (less than 3 months) myocardi... [+5]

Status: Not yet recruiting

Seated Ankle Robot for Foot Drop in Aging and Disabled Populations: A Demonstration Project

The purpose of this research study is to test the utility of an ankle robot in people with ankle weakness and foot drop from a peripheral nervous system injury due to neuromuscular or orthopedic injury.

Participants needed: 100
Trial details
Age: 18-88Biological sex: AllType: InterventionalSponsor: Baltimore VA Medical CenterUpdated: May 21, 2018Locations: 1
Eligibility criteria

Men and women, aged 18 to 88 years [+2]

Medical history that would preclude participation in low-intensity seated roboti... [+3]